Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanping Meng

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|April 23, 2026
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Frontiers in Immunology|May 13, 2026
Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Biomedicines|June 27, 2024
Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination TherapyYaoru Song, Shida Pan, Jiahe Tian, et al.
Gastroenterology|March 17, 2018
Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of PatientsXiaowen Wang, Qingyang Dong, Qian Li, et al.
Frontiers in Immunology|March 26, 2025
Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort studyShida Pan, Jianing Wang, Jiahe Tian, et al.
Journal of Neuroimmunology|February 11, 2003
Experimental autoimmune myasthenia gravis in mice expressing human immunoglobulin lociMaurice H W Stassen, Fanping Meng, Eefje Melgert, et al.
Advances in Therapy|August 30, 2020
Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational StudyXiangbo Xu, Bang Liu, Su Lin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 6, 2023
Clinical relevance of plasma EBV DNA as a biomarker for nasopharyngeal carcinoma in non-endemic areas: A multicenter study in southwestern ChinaQiao He, Yi Zhou, Jie Zhou, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2025
Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world studyYilin Wang, Shida Pan, Jiahe Tian, et al.
Gut Microbes|March 8, 2021
Integrated gut virome and bacteriome dynamics in COVID-19 patientsJiabao Cao, Cheng Wang, Yuqing Zhang, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|April 23, 2026
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Frontiers in Immunology|May 13, 2026
Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemiaJianing Wang, Shida Pan, Chuyue Xiong, et al.
Biomedicines|June 27, 2024
Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination TherapyYaoru Song, Shida Pan, Jiahe Tian, et al.
Gastroenterology|March 17, 2018
Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of PatientsXiaowen Wang, Qingyang Dong, Qian Li, et al.
Frontiers in Immunology|March 26, 2025
Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort studyShida Pan, Jianing Wang, Jiahe Tian, et al.
Journal of Neuroimmunology|February 11, 2003
Experimental autoimmune myasthenia gravis in mice expressing human immunoglobulin lociMaurice H W Stassen, Fanping Meng, Eefje Melgert, et al.
Advances in Therapy|August 30, 2020
Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational StudyXiangbo Xu, Bang Liu, Su Lin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 6, 2023
Clinical relevance of plasma EBV DNA as a biomarker for nasopharyngeal carcinoma in non-endemic areas: A multicenter study in southwestern ChinaQiao He, Yi Zhou, Jie Zhou, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2025
Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world studyYilin Wang, Shida Pan, Jiahe Tian, et al.
Gut Microbes|March 8, 2021
Integrated gut virome and bacteriome dynamics in COVID-19 patientsJiabao Cao, Cheng Wang, Yuqing Zhang, et al.
Pageof 12